pasireotide
pasireotide is listed in the FDA National Drug Code directory with 13 NDC codes, marketed under brand names including Signifor, Signifor LAR. Available dosage forms: injection, kit, injection, powder, for suspension.
Drug Details
- Generic Name
- pasireotide
- Brand Names
- Signifor, Signifor LAR
- Application Number
- NDA200677
- Sponsor
- Recordati Rare Diseases, Inc.
- NDC Codes
- 13
- Dosage Forms
- INJECTION, KIT, INJECTION, POWDER, FOR SUSPENSION
- Routes
- SUBCUTANEOUS
- Active Ingredients
- PASIREOTIDE
Indications and Usage
1 INDICATIONS AND USAGE SIGNIFOR LAR is a somatostatin analog indicated for the treatment of: Patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. ( 1.1 ) Patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative. ( 1.2 ) 1.1 Acromegaly SIGNIFOR LAR is indicated for the treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. 1.2 Cushing's Disease SIGNIFOR LAR is indicated for the treatment of patients with Cushing's disease for whom pituitary surgery is not an option or has not been curative.